STAR and metabolic dysfunction-associated steatohepatitis: Furthermore, free cholesterol is increased in liver tissue from patients with non-alcoholic steatohepatitis (NASH), and this is associated to an increment in the expression of the sterol regulatory element binding protein (SREBP) 2 and steroidogenic acute regulatory protein (StAR) [9], both critically linked to HCC development and progression [10].